Drug class
Salicylanilide anthelmintic; cestocidal agent
Mechanism of action
Interferes with mitochondrial energy metabolism and oxidative phosphorylation in cestodes, disrupting ATP production and causing death of the parasite. It is poorly absorbed from the gastrointestinal tract.
General use cases
- Treatment of intestinal tapeworm infections (taeniasis) caused by susceptible cestodes in countries where oral niclosamide is authorised; it is not a treatment for tissue-invasive larval tapeworm disease
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
